{
    "title": "110_s1479",
    "content": "The \"Safe Tissue Act\" defines key terms like \"establishment,\" \"human cells, tissues, or cellular or tissue-based products,\" and \"Secretary.\" It also outlines inspections and audits by the FDA. The FDA conducts inspections of tissue banks every 2 years and may establish a user fee program for funding. Audits are also conducted to ensure compliance with legal requirements for obtaining human cells and tissues. The FDA conducts inspections of tissue banks every 2 years to ensure compliance with legal requirements for obtaining human cells and tissues, including verifying that products are obtained legally, donor eligibility is based on accurate information, and current good tissue practices are followed. The FDA conducts inspections of tissue banks every 2 years to ensure compliance with legal requirements for obtaining human cells and tissues. SEC. 4. DEVELOPMENT OF MODEL CONSENT FORM. The Secretary will publish a model form in the Federal Register with minimum requirements for establishments to obtain consent from potential donors of human cells, tissues, or products. The form will include details on the type of donation, purpose of use, and consent requirements. The Secretary will establish requirements for establishments to obtain consent directly from potential donors or their representatives for the recovery process of human cells, tissues, or products. This includes providing a description of the recovery process upon request and informing donors of their right to receive this information. The Secretary will establish regulations requiring establishments to provide a description of the recovery process to donors and inform them of their right to receive this information. Failure to comply may result in a civil penalty of up to $5,000. The establishment or individual using fraudulent information to obtain consent may face fines up to $10,000 or imprisonment for up to 6 months for the first violation, and fines up to $250,000 or imprisonment for up to 10 years for subsequent violations. The model form regulations will override any laws related to obtaining consent for human cell or tissue donation. The model form regulations will override any laws related to obtaining consent for human cell or tissue donation, representative of a potential donor in the State where the establishment operates. SEC. 5. ACCREDITATION OF ESTABLISHMENTS AND PERSONNEL. The Secretary will create regulations to accredit establishments and personnel involved in human cell or tissue products. The accreditation process will be based on the Joint Commission on Accreditation of Healthcare Organizations or an existing private entity process. The Secretary will define \"reasonable payments\" for human tissue products regulated under part 1271 of title 21, United States Code."
}